Even the best stock pickers will make plenty of bad investments. Anyone who held Winning Health Technology Group Co., Ltd. (SZSE:300253) over the last year knows what a loser feels like. The share price is down a hefty 57% in that time. Even if you look out three years, the returns are still disappointing, with the share price down49% in that time. Shareholders have had an even rougher run lately, with the share price down 30% in the last 90 days.
With the stock having lost 4.0% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.
View our latest analysis for Winning Health Technology Group
There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.
Unfortunately Winning Health Technology Group reported an EPS drop of 37% for the last year. The share price decline of 57% is actually more than the EPS drop. So it seems the market was too confident about the business, a year ago.
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
SZSE:300253 Earnings Per Share Growth September 26th 2022
This free interactive report on Winning Health Technology Group's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.
A Different Perspective
We regret to report that Winning Health Technology Group shareholders are down 57% for the year (even including dividends). Unfortunately, that's worse than the broader market decline of 17%. However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Longer term investors wouldn't be so upset, since they would have made 1.3%, each year, over five years. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Winning Health Technology Group that you should be aware of before investing here.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CN exchanges.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
即使是最好的选股者也会做出大量糟糕的投资。任何持有赢利健康科技集团有限公司。(SZSE:300253)在过去的一年里,我知道失败者是什么感觉。在此期间,该公司股价大幅下跌了57%。即使你放眼三年,回报仍然令人失望,在此期间股价下跌了49%。股东们最近经历了更艰难的时期,股价在过去90天里下跌了30%。
鉴于该公司股价在过去一周下跌了4.0%,我们有必要看看公司的业绩,看看是否有任何危险信号。
查看我们赢得健康科技组的最新分析
不可否认,市场有时是有效的,但价格并不总是反映潜在的商业表现。一种不完美但简单的方法来考虑市场对一家公司的看法是如何改变的,那就是将每股收益(EPS)的变化与股价走势进行比较。
不幸的是,Winning Health Technology Group报告去年每股收益下降了37%。股价57%的跌幅实际上比每股收益的跌幅还要大。因此,一年前,市场似乎对这项业务过于自信。
下图显示了EPS是如何随着时间的推移进行跟踪的(如果您点击该图像,您可以看到更多详细信息)。
深交所:2022年9月26日每股收益增长300253
这免费如果你想进一步调查健康科技集团的股票,那么关于赢得健康科技集团的收益、收入和现金流的互动报告是一个很好的起点。
不同的视角
我们遗憾地报告,赢得健康科技集团的股东今年以来下降了57%(甚至包括股息)。不幸的是,这比大盘17%的跌幅还要糟糕。然而,这可能只是因为股价受到了更广泛的市场紧张情绪的影响。也许有必要关注基本面,以防出现良机。较长期的投资者不会如此沮丧,因为他们在五年内每年会获得1.3%的收益。如果基本面数据继续显示长期可持续增长,当前的抛售可能是一个值得考虑的机会。虽然值得考虑市场状况对股价可能产生的不同影响,但还有其他更重要的因素。例如,我们发现健康科技组获奖的2个警示标志在这里投资之前你应该意识到这一点。
当然了,如果你把目光投向别处,你可能会发现这是一笔很棒的投资。所以让我们来看看这个免费我们预计收益将会增长的公司名单。
请注意,本文引用的市场回报反映了目前在CN交易所交易的股票的市场加权平均回报。
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。